{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:41:57Z","timestamp":1780328517418,"version":"3.54.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["onlinejcf.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.cardfail.2024.10.444","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T22:17:05Z","timestamp":1732832225000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Utility of Mechanistic Target of Rapamycin Inhibitors in Cardiac Sarcoidosis"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8381-6033","authenticated-orcid":false,"given":"DONALD","family":"RICHARDS","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIDESATO","family":"FUJITO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AAKASH","family":"SHANBHAG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BOBAK","family":"AKHAVAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ELIZABETH","family":"FRAME","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SEAN","family":"HAYES","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JOHN","family":"FRIEDMAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LOUISE","family":"THOMSON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PIOTR","family":"SLOMKA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DANIEL","family":"BERMAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0507-2412","authenticated-orcid":false,"given":"EVAN P.","family":"KRANSDORF","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2024.10.444_bib0001","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cardfail.2021.06.016","article-title":"Sarcoidosis-related cardiomyopathy: current knowledge, challenges, and future perspectives state-of-the-art review","volume":"28","author":"Gilotra","year":"2022","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2024.10.444_bib0002","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00430-2019","article-title":"Exome sequencing and pathogenicity-network analysis of five French families implicate mTOR signalling and autophagy in familial sarcoidosis","volume":"54","author":"Calender","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cardfail.2024.10.444_bib0003","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030478","article-title":"An mTORC1-dependent mouse model for cardiac sarcoidosis","volume":"12","author":"Bueno-Beti","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cardfail.2024.10.444_bib0004","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1600-6143.2006.01290.x","article-title":"Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report","volume":"6","author":"Kobashigawa","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cardfail.2024.10.444_bib0005","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/ajt.12181","article-title":"Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial","volume":"13","author":"Eisen","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cardfail.2024.10.444_bib0006","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12350-020-02201-5","article-title":"Quantitative assessment of cardiac hypermetabolism and perfusion for diagnosis of cardiac sarcoidosis","volume":"29","author":"Miller","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.cardfail.2024.10.444_bib0007","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jcmg.2024.01.006","article-title":"AI-defined cardiac anatomy improves risk stratification of hybrid perfusion imaging","volume":"17","author":"Miller","year":"2024","journal-title":"JACC Cardiovasc Imag"},{"key":"10.1016\/j.cardfail.2024.10.444_bib0008","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jcmg.2023.05.017","article-title":"prospective analysis of immunosuppressive therapy in cardiac sarcoidosis with fluorodeoxyglucose myocardial accumulation: the PRESTIGE study","volume":"17","author":"Morimoto","year":"2024","journal-title":"JACC Cardiovasc Imag"},{"key":"10.1016\/j.cardfail.2024.10.444_bib0009","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.jcmg.2020.11.016","article-title":"Pre-treatment myocardial (18)FDG uptake predicts response to immunosuppression in patients with cardiac sarcoidosis","volume":"14","author":"Subramanian","year":"2021","journal-title":"JACC Cardiovasc Imag"},{"key":"10.1016\/j.cardfail.2024.10.444_bib0010","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1399-0012.2007.00686.x","article-title":"Comparison of sirolimus and everolimus in their effects on blood lipid profiles and haematological parameters in heart transplant recipients","volume":"21","author":"Tenderich","year":"2007","journal-title":"Clin Transplant"},{"key":"10.1016\/j.cardfail.2024.10.444_bib0011","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/ni.3655","article-title":"Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression","volume":"18","author":"Linke","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cardfail.2024.10.444_bib0012","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1164\/rccm.202004-0914IM","article-title":"Successful response to treatment with sirolimus in pulmonary sarcoidosis","volume":"202","author":"Gupta","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cardfail.2024.10.444_bib0013","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/S2665-9913(23)00302-8","article-title":"Efficacy and safety of mTOR inhibition in cutaneous sarcoidosis: a single-centre trial","volume":"6","author":"Redl","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.cardfail.2024.10.444_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152102","article-title":"Sarcoidosis incidence after mTOR inhibitor treatment","volume":"57","author":"Baker","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.cardfail.2024.10.444_bib0015","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jacc.2022.10.021","article-title":"Genetic cardiomyopathy masquerading as cardiac sarcoidosis","volume":"81","author":"Lal","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2024.10.444_bib0016","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1161\/CIRCGEN.122.003850","article-title":"Prevalence of pathogenic variants in dilated cardiomyopathy-associated genes in patients evaluated for cardiac sarcoidosis","volume":"16","author":"Reza","year":"2023","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.cardfail.2024.10.444_bib0017","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1161\/CIRCGEN.123.004099","article-title":"Cardiac sarcoidosis mimickers: genetic testing in undifferentiated inflammatory cardiomyopathies","volume":"16","author":"Castrichini","year":"2023","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.cardfail.2024.10.444_bib0018","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jacep.2023.12.010","article-title":"Genetic cardiomyopathies misdiagnosed as cardiac sarcoidosis","volume":"10","author":"Subramanian","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.cardfail.2024.10.444_bib0019","article-title":"Features and clinical impact of extra-cardiac lesions with (18)F-fluorodeoxyglucose positron emission tomography in patients with suspected cardiac sarcoidosis","volume":"30","author":"Higashi","year":"2020","journal-title":"Int J Cardiol Heart Vasc"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916424009291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916424009291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T21:12:30Z","timestamp":1734642750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916424009291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":19,"alternative-id":["S1071916424009291"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2024.10.444","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility of Mechanistic Target of Rapamycin Inhibitors in Cardiac Sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2024.10.444","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}